SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR is drawing attention after traders linked its sharp rally to the launch of confidential perpetual contracts powered by Hyperliquid, bringing privacy to leveraged on-chain trading. The community is broadly bullish on NEARs AI, privacy, and cross-chain positioning, though some traders attribute the move to momentum, liquidity, or short covering rather than a durable fundamental catalyst.

Sui s a Layer 1 blockchain developed by Mysten Labs, a team founded by former lead engineers from Meta’s blockchain research division. It is designed for global adoption by providing a secure, high-speed environment for digital asset ownership and removing technical barriers for Web3 applications. The platform utilizes the Move programming language to create a safe framework and supports horizontal scaling to keep fees stable and speeds high as the network grows. Significant institutional support comes from major venture capital firms including Andreessen Horowitz, Coinbase Ventures, Circle Ventures, and YZi Labs.  The system functions by organizing data into independent objects rather than a single ledger of accounts. This object-centric data model enables parallel execution, allowing the network to process many transactions simultaneously instead of waiting for one to finish before starting the next. This architecture is built for rapid transaction finalization to ensure near-instant results. To maintain long-term stability, the network collects fees into a storage fund that rewards validators for keeping data on the network indefinitely.  Sui offers several advanced tools including zkLogin for easier account access and sponsored transactions that allow users to interact with apps without managing complex wallets or immediate fees. Developers can also create tailored object types that work across the entire network, which encourages innovation and deep composability. These features are designed to create a more user-friendly experience for interacting with decentralized applications and digital games.  The SUI token is central to the ecosystem, serving as the primary asset for transaction fees and on-chain utility within decentralized exchanges and lending platforms. Users participate in a proof-of-stake mechanism by locking their tokens to support validators and secure the blockchain in exchange for rewards. Additionally, token holders have a role in governance, allowing them to participate in voting on network rules and future protocol upgrades. Value moves through the system through these staking rewards and transaction fees to ensure the platform scales sustainably

Repeated Sui mainnet outages and transaction halts, including problems linked by traders to a software upgrade, are driving attention and raising concerns about the networks reliability and security. The community is split between bearish holders citing outages, tokenomics and prior exploits, and dip buyers highlighting gasless stablecoin transfers, staking and longer-term adoption potential.

Avalanche is a high throughput smart contract blockchain&nbsp;platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

A sharp, high-volume rebound is driving attention, with traders linking the move to Avalanches institutional and real-world-asset tokenization narrative, including reported NYSE testing and expanded brokerage access. Bulls view the activity as renewed adoption and altcoin momentum, while skeptics argue that AVAXs rallies repeatedly fade into pump-and-dump moves.

Stellar is an open-source, decentralized network co-founded in 2014 by Jed McCaleb and Joyce Kim to facilitate the fast and low-cost transfer of value across different currencies and assets globally. Managed by the non-profit Stellar Development Foundation, the project serves as a global infrastructure that connects banks, payment systems, and individuals to expand financial access to underserved populations. Its main value proposition lies in providing a bridge between traditional money and digital networks through the use of Anchors, which are trusted entities that hold deposits and issue credits on the ledger.  The network operates using the Stellar Consensus Protocol and a Federated Byzantine Agreement, where nodes choose trusted sets of other nodes to agree on the state of the ledger. This system ensures high throughput and fast finality, where transactions are considered permanent and irreversible within seconds. Key features include a built-in distributed exchange for trading assets without intermediaries and the Soroban platform for developing smart contracts. Users can also utilize the network for tokenizing real-world assets or accessing decentralized finance services like peer-to-peer lending.  Stellar's native token, XLM, is essential for maintaining network integrity by acting as an intermediary to find efficient exchange paths and preventing spam through small transaction fees and minimum account balance requirements. Unlike many other digital assets, the network has no inflation because the community voted to disable the automatic creation of new tokens. While the project received early funding from the payments company Stripe, it is now sustained by a global community of validators and developers rather than traditional venture capital.

Stellar Lumens

Regulatory clarityparticularly speculation around the Clarity Act and forthcoming SEC/CFTC crypto rulesis the dominant catalyst, with traders also citing Stellars potential role in institutional payments and tokenized assets. Bulls expect these developments and reported partnerships to drive adoption, while skeptics argue repeated pumps have quickly sold off and XLM continues to lag despite the hype.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

A sharp rebound through a key resistance area, accompanied by elevated volume, has renewed attention around ALGO as traders debate whether the move signals a breakout from long-term lows. Bulls point to post-quantum upgrades, new leadership and a potential altcoin cycle, while skeptics cite dilution, weak adoption and the risk of another reversal.

Terra is a decentralized financial payment network that rebuilds the traditional payment stack on the blockchain. Luna is the reserve currency of the Terra platform. It has three core functions: i) mine Terra transactions through staking, ii) ensure the price stability of Terra stablecoins and iii) provide incentives for the platform’s blockchain validators.

Terra Luna Classic

Speculation around Terra Classics burn and repeg roadmapparticularly Market Module 2.0, Binance/community burns, and possible court-related token reductionsis driving attention. Traders are divided between bullish comeback expectations and skepticism about LUNCs large supply, weak liquidity, and recurring pump-and-dump behavior.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Merck and Modernas personalized mRNA cancer vaccine, used with Keytruda, met key Phase 3 endpoints in resected melanoma, boosting interest in Mercks oncology pipeline and potential protection against the Keytruda patent cliff. Traders largely view the result as validation of cancer vaccines, while others caution that full data, overall-survival results, regulatory approval and the therapys commercial scale remain uncertain.

Litecoin is a decentralized, peer-to-peer digital currency designed to enable instant, near-zero cost payments to individuals and merchants worldwide. As an open-source global payment network that functions independently of central banks or intermediaries, its main value proposition lies in providing a scarce digital asset with a fixed maximum supply of 84 million tokens.  The network operates using a Proof of Work mechanism where computers solve complex puzzles to confirm transactions and secure the blockchain. It is distinguished by a block generation time of 2.5 minutes, which allows for faster transaction confirmations and a higher total throughput than earlier protocols. Key technical features include the Scrypt hashing algorithm, which promotes wider network participation, and MimbleWimble Extension Blocks, which improve user privacy by allowing transaction details to be hidden.  The LTC token is used for settling global payments, executing microtransactions through smaller units called litoshis, and diversifying digital portfolios with a highly liquid asset. New tokens are issued to miners as rewards for verifying blocks, though these rewards undergo a halving event approximately every four years to strictly control inflation. This process ensures the ledger maintains immutability, meaning records cannot be changed once they are saved to the global network.  Created by former Google engineer Charlie Lee, the project is supported by the Litecoin Foundation, a non-profit organization dedicated to ecosystem adoption. Unlike many venture-backed projects, it is maintained by a decentralized community of independent developers and a global network of miners. The project has seen recent institutional adoption, with entities like Lite Strategy and Luxxfolio Holdings adding significant amounts of LTC to their corporate treasuries as of late 2025.

Litecoin

A technical breakout attempt and improving momentum are driving attention, with traders highlighting resistance being cleared, rising volume, and the possibility of a short squeeze or broader altcoin rotation. Bullish traders expect Litecoin to catch up, while skeptics point to its persistent underperformance and history of reversing gains.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

Precigen is drawing attention after strong second-quarter results showed rapidly accelerating PAPZIMEOS commercialization, improved profitability, and progress toward cash-flow breakeven. Traders are broadly bullish on the launch and upcoming European approval and PRGN-2009 data, while debate continues over short interest, options-related volatility, and whether the strong fundamentals are fully reflected in the share price.

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the following segments: Materials and Magnetics. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

Uncertainty around U.S.-China trade talks and Chinas rare-earth export restrictions is driving attention to MP as a key U.S. supplier. Traders are split between viewing tighter Chinese supply and continued U.S. government support as bullish for domestic magnets, while warning that any agreement easing tensions could weigh on MP in the near term.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Edesa Biotech Stock Sinks After Fresh Capital Raise

Edesa Biotech Stock falls in premarket trading as investors weigh a $25 million offering, new warrants and potential dilution.read more...

EDSA Stock Soars More Than 700% So Far This Year: Wall Street Eyes Further Upside In Run Up To Acute Kidney Injury Data Reveal

Equity

According to data from Koyfin, the sole analyst covering EDSA rates it a ‘Buy’ with a $14 price target.


Edesa Biotech (EDSA) to Release Earnings on Tuesday

Edesa Biotech (NASDAQ:EDSA) will be releasing earnings before the market opens on Tuesday, May 12. (View Earnings Report at...

Short Interest in Edesa Biotech, Inc. (NASDAQ:EDSA) Decreases By 32.5%

Edesa Biotech, Inc. (NASDAQ:EDSA - Get Free Report) saw a large decline in short interest in April. As of April 15th, there was short interest totaling 267,664 shares, a decline of 32.5% from the...

EDSA Stock Rallied Over 50% Today: What’s Ahead For The Small-Cap Biotech?

The rally comes ahead of the company CEO’s upcoming presentation at the ATS 2026 Respiratory Innovation Summit (RIS) and other pipeline catalysts.

Edesa Biotech (NASDAQ:EDSA) Rating Increased to Hold at Wall Street Zen

Wall Street Zen raised Edesa Biotech from a "sell" rating to a "hold" rating in a research note on Sunday...

Short Interest in Edesa Biotech, Inc. (NASDAQ:EDSA) Expands By 9,253.7%

Edesa Biotech, Inc. (NASDAQ:EDSA - Get Free Report) saw a significant increase in short interest during the month of February. As of February 27th, there was short interest totaling 1,411,103 shares...

Best Biotech Stocks To Follow Today - March 7th

Danaher, Moderna, Vertex Pharmaceuticals, argenex, Iovance Biotherapeutics, Edesa Biotech, and ImmunityBio are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool...

Pardeep Nijhawan Purchases 10,000 Shares of Edesa Biotech (NASDAQ:EDSA) Stock

Edesa Biotech, Inc. (NASDAQ:EDSA - Get Free Report) CEO Pardeep Nijhawan purchased 10,000 shares of Edesa Biotech stock in a transaction dated Thursday, March 5th. The shares were purchased at an...

Edesa Biotech (NASDAQ:EDSA) CEO Pardeep Nijhawan Acquires 10,000 Shares

Edesa Biotech, Inc. (NASDAQ:EDSA - Get Free Report) CEO Pardeep Nijhawan purchased 10,000 shares of the firm's stock in a transaction on Thursday, March 5th. The shares were acquired at an average...

Edesa Biotech, Inc. is a biopharmaceutical company, which focuses on acquisition, development, and commercialization of drug candidates for medical dermatology and respiratory diseases. Its clinical studies include EB05 for Acute Respiratory Distress Syndrome (ARDS), EB07 for systemic sclerosis (SSc), EB01 for chronic Allergic Contact Dermatitis (ACD), and EB06 for vitiligo. The company was founded by Pardeep Nijhawan on June 12, 2007 and is headquartered in Markham, Canada.

Edesa Biotech Inc

Bearish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$4.14
Prev Close	$4.14
Open	$4.03
Dividend Yield	0.00%
50-Day Moving Average	$5.20
Beta	0.46
Avg. Volume	90,249.74
PE Ratio	-2.45

52-Week High	$20.32
52-Week Low	$0.72
Market Capitalization	$55.94M
EPS (Annual)	-$1.27
Price to Book	99.95
Revenue Per Employee	$0.00

Feed

News

Sentiment

Fundamentals

Info

EDSA Fundamentals